Chester County News and Community Website
WILMINGTON, DE — Whispeara, a natural hearing supplement, is making waves as a holistic solution for auditory and cognitive health challenges. Developed with carefully selected herbal extracts, vitamins, and minerals, the …
Whispeara Gains Attention as a Breakthrough in Hearing Support Read More
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) has finalized the sale of its Avoca business to Mane, effective March 14, 2025. While the financial terms of the deal remain undisclosed, the …
Ashland Sells Avoca Business to Mane Read More
WILMINGTON, DE — Global Indemnity Group, LLC (NYSE: GBLI) has announced that its Board of Directors approved a distribution payment of $0.35 per common share.
Global Indemnity Announces $0.35 Per Share Distribution for March 2025 Read More WILMINGTON, DE — Global Indemnity Group, LLC (NYSE:GBLI) closed out 2024 with remarkable financial results, posting a 71% rise in net income available to shareholders, reaching $42.8 million or $3.12 per …
Global Indemnity Reports Robust 2024 Financial Performance Read More
WILMINGTON, DE — NiKang Therapeutics® Inc. has achieved a pivotal step in the development of its first-in-class CDK2 degrader, NKT3964, by completing the dosing of the first patient cohort in a …
NiKang Advances CDK2 Degrader with Key Milestone in Cancer Treatment Trial Read More
WILMINGTON, DE & WHIPPANY, NJ — The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by adding sterile injectable manufacturing capabilities. …
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing Read More
WILMINGTON, DE — The Apache Software Foundation (ASF) has announced that Apache Uniffle has officially graduated from incubation to become a Top-Level Project (TLP). This milestone underscores the maturity and …
Apache Uniffle Becomes ASF Top-Level Project Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has released its 2024 financial results and provided an update on its clinical pipeline, underscoring significant progress in its precision oncology programs. The …
Prelude Therapeutics Reports 2024 Financial Results and Clinical Pipeline Advancements Read More
WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) has significantly raised its first-quarter 2025 guidance after signing a new multi-year, royalty-bearing license agreement with a leading Chinese smartphone manufacturer. This agreement enhances …
InterDigital Updates Q1 2025 Outlook After Major Smartphone Licensing Deal Read More
WILMINGTON, DE — Acorn Energy, Inc. (OTCQB: ACFN) has announced its financial results for the fourth quarter and full year of 2024, highlighting significant growth in revenue, net income, and …
Acorn Energy Reports Strong 2024 Results, Plans Nasdaq Uplisting Read More